Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Targeting melanoma with multifunctional nanoparticles

EF 2013-14

Résumé
Nanoparticles are being explored as promising therapeutic agents for overcoming multidrug resistance, which is common in melanoma. Gold nanoparticles and carbon nanotubes can deliver cancer drugs to tumours more efficiently due to their small size and the enhanced permeability and retention effect (EPR). These nanoparticles can also be used to improve the outcomes from x-ray therapy and localized heat therapy due to their unique physical properties, which make them ideal candidates in multimodal cancer therapy. However, the EPR effect is not well established in human cancers, so improved methods of targeting nanoparticles need to be sought to improve how many of the nanoparticles accumulate at the desired tumour site. Controlling the duration of retention and route of excretion of the nanoparticles is also important due to long-term toxicity concerns and limiting undesired biological interactions in the body. The objective of this project is to manipulate the surface chemistry of nanoparticle systems to control their tumour delivery, retention, elimination, and compatibility for multimodal treatment for optimal efficacy in melanoma treatment. It is expected that the optimization of size and surface chemistry of nanoparticles can lead to a robust EPR effect in melanoma to improve tumour uptake and retention. The findings of this project will represent a proof-of-concept for a new methodology in delivering multimodal therapy to melanoma. The application of concurrent chemotherapy, x-ray therapy, and heat therapy may improve disease free survival and overall survival in melanoma patients.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
307831
Name
Poon Wilson
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Targeting melanoma with multifunctional nanoparticles
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Active Targeting; Animal Imaging; Chemotherapy; Melanoma; Nanomedicine; Nanoparticles; Radiotherapy; Surface Chemistry
Abstract
Nanoparticles are being explored as promising therapeutic agents for overcoming multidrug resistance, which is common in melanoma. Gold nanoparticles and carbon nanotubes can deliver cancer drugs to tumours more efficiently due to their small size and the enhanced permeability and retention effect (EPR). These nanoparticles can also be used to improve the outcomes from x-ray therapy and localized heat therapy due to their unique physical properties, which make them ideal candidates in multimodal cancer therapy. However, the EPR effect is not well established in human cancers, so improved methods of targeting nanoparticles need to be sought to improve how many of the nanoparticles accumulate at the desired tumour site. Controlling the duration of retention and route of excretion of the nanoparticles is also important due to long-term toxicity concerns and limiting undesired biological interactions in the body. The objective of this project is to manipulate the surface chemistry of nanoparticle systems to control their tumour delivery, retention, elimination, and compatibility for multimodal treatment for optimal efficacy in melanoma treatment. It is expected that the optimization of size and surface chemistry of nanoparticles can lead to a robust EPR effect in melanoma to improve tumour uptake and retention. The findings of this project will represent a proof-of-concept for a new methodology in delivering multimodal therapy to melanoma. The application of concurrent chemotherapy, x-ray therapy, and heat therapy may improve disease free survival and overall survival in melanoma patients.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Poon, Wilson
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~